These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20965587)

  • 1. Reduced body iron stores and atherosclerosis in patients with cyanotic congenital heart disease.
    Mascitelli L; Pezzetta F; Goldstein MR
    Int J Cardiol; 2011 Jan; 146(1):117. PubMed ID: 20965587
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blood serum iron and total iron-binding capacity in children with congenital cyanotic heart defects].
    Wróblewska-Kaluzewska M
    Pediatr Pol; 1970 Feb; 45(2):187-96. PubMed ID: 5437022
    [No Abstract]   [Full Text] [Related]  

  • 3. Iron deficiency in a patient with extreme erythrocytosis due to cyanotic congenital heart disease.
    Braun SL; Eicken A; Kaemmerer H
    Int J Cardiol; 2007 Mar; 116(2):e74-5. PubMed ID: 17097163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NEU3 sialidase role in activating HIF-1α in response to chronic hypoxia in cyanotic congenital heart patients.
    Piccoli M; Conforti E; Varrica A; Ghiroldi A; Cirillo F; Resmini G; Pluchinotta F; Tettamanti G; Giamberti A; Frigiola A; Anastasia L
    Int J Cardiol; 2017 Mar; 230():6-13. PubMed ID: 28038803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hypoxia-inducible factor HIF-1 promotes intramyocardial expression of VEGF in infants with congenital cardiac defects.
    Qing M; Görlach A; Schumacher K; Wöltje M; Vazquez-Jimenez JF; Hess J; Seghaye MC
    Basic Res Cardiol; 2007 May; 102(3):224-32. PubMed ID: 17268888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoglycaemia in infants and children with cyanotic congenital heart disease.
    Gács G; Kun E; Berend K
    Acta Paediatr Acad Sci Hung; 1973; 14(2):105-11. PubMed ID: 4763559
    [No Abstract]   [Full Text] [Related]  

  • 7. Halothane metabolism in acyanotic and cyanotic patients undergoing open heart surgery.
    Moore RA; McNicholas KW; Gallagher JD; Gandolfi AJ; Sipes IG; Kerns D; Clark DL
    Anesth Analg; 1986 Dec; 65(12):1257-62. PubMed ID: 3777453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free amino acids in hearts of pediatric patients with congenital heart disease: the effects of cyanosis, age, and pathology.
    Modi P; Suleiman MS; Reeves BC; Pawade A; Parry AJ; Angelini GD; Caputo M
    Ann Thorac Surg; 2006 Mar; 81(3):943-9. PubMed ID: 16488699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemoptysis in patients with congenital cyanotic heart disease].
    Martínez Algar JL; García Entrena A; Castillo Martínez CM; Azcón González de Aguilar P; Gualda Cantón J; Ortega Martos L
    An Esp Pediatr; 1997 Jul; 47(1):80-2. PubMed ID: 9382337
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of stroke in adults with cyanotic congenital heart disease.
    Bridges ND
    Circulation; 1994 Feb; 89(2):911. PubMed ID: 8313583
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinogen metabolism in cyanoti congenital heart disease.
    Goldschmidt B; Siegler J; Schmidt M
    Haematologia (Budap); 1977; 11(1-2):169-76. PubMed ID: 615088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal metabolic state of hearts of patients with congenital heart disease: the effects of cyanosis, age, and pathology.
    Modi P; Suleiman MS; Reeves BC; Pawade A; Parry AJ; Angelini GD; Caputo M
    Ann Thorac Surg; 2004 Nov; 78(5):1710-6. PubMed ID: 15511460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional hyposplenia in cyanotic congenital heart disease.
    Pearson HA; Schiebler GL; Spencer RP
    Pediatrics; 1971 Aug; 48(2):277-80. PubMed ID: 5560621
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypernatremia in a patient with cyanotic congenital heart disease.
    Capel I; Subirana MT; Rodríguez-Espinosa J; Corcoy R
    Int J Cardiol; 2008 Jul; 127(3):e116-7. PubMed ID: 17764765
    [No Abstract]   [Full Text] [Related]  

  • 15. Measurement of cerebral-oxygenation status when commencing cardiopulmonary bypass in pediatric open-heart surgery.
    Murayama H; Tamaki S; Usui A; Ueda Y
    Ann Thorac Cardiovasc Surg; 2006 Apr; 12(2):105-12. PubMed ID: 16702931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral abscess in patients with congenital cyanotic heart disease.
    Kalyanaraman S; Ramanujam PB; Ramamurthi B
    Neurol India; 1970 Dec; 18():Suppl 1:96-9. PubMed ID: 5508117
    [No Abstract]   [Full Text] [Related]  

  • 17. Coagulation abnormalities in patients with cyanotic congenital heart disease.
    Tempe DK; Virmani S
    J Cardiothorac Vasc Anesth; 2002 Dec; 16(6):752-65. PubMed ID: 12486661
    [No Abstract]   [Full Text] [Related]  

  • 18. [Remarks on the problem of anoxemic attacks in cyanotic heart defects].
    Skotnicki S; Iljin W
    Pediatr Pol; 1968 May; 43(5):625-7. PubMed ID: 5669062
    [No Abstract]   [Full Text] [Related]  

  • 19. Paraganglioma and cyanotic congenital heart disease: The role of tisular hipoxia.
    Oleaga-Alday A; Goñi-Goicoechea F; Calles-Romero L; Pérez de Ciriza-Cordeu M; Paja-Fano M
    Endocrinol Nutr; 2015 Oct; 62(8):413-4. PubMed ID: 26112697
    [No Abstract]   [Full Text] [Related]  

  • 20. Medical management of congenital cyanotic heart disease.
    Sukumar IP; Vijayaraghavan G
    Indian Heart J Teach Ser; 1976 Jun; 1(1):53-6. PubMed ID: 1052330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.